Cargando…
Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity
[Image: see text] Lysosomal cysteine peptidase cathepsin B (catB) is an important tumor-promoting factor involved in tumor progression and metastasis representing a relevant target for the development of new antitumor agents. In the present study, we synthesized 11 ruthenium compounds bearing either...
Autores principales: | Mitrović, Ana, Kljun, Jakob, Sosič, Izidor, Uršič, Matija, Meden, Anton, Gobec, Stanislav, Kos, Janko, Turel, Iztok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751773/ https://www.ncbi.nlm.nih.gov/pubmed/31464130 http://dx.doi.org/10.1021/acs.inorgchem.9b01882 |
Ejemplares similares
-
Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity
por: Mirković, Bojana, et al.
Publicado: (2015) -
Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection
por: Milan Bonotto, Rafaela, et al.
Publicado: (2023) -
Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo
por: Mitrović, Ana, et al.
Publicado: (2017) -
Redox-Based Inactivation of Cysteine Cathepsins by Compounds Containing the 4-Aminophenol Moiety
por: Mirković, Bojana, et al.
Publicado: (2011) -
Synthesis and Structural Evaluation of Organo-Ruthenium Complexes with β-Diketonates
por: Uršič, Matija, et al.
Publicado: (2017)